Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s Life Science Investor Konference held in Copenhagen on November 27th 2024. Økonomisk Ugebrev, serves as a platform for collaboration and investment opportunities. Hamlet BioPharma presented the advances made by the …
